MTND5P41

Across TCGA pan-cancer cohorts, MTND5P41 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MTND5P41 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MTND5P41 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND5P41 expression acts as an unfavorable survival marker.

STAD and ACC are the cancer types where MTND5P41 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.273	0.569	<.001	171	view →
ACC	DFS	Tertile	All	0.057	0.623	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MTND5P41–STAD (DFS)

Open the STAD breakdown →